One World Products, Inc. income statement OWPC

In fiscal 2024, which ended Dec 31, 2024, One World Products, Inc. reported revenue of $4,863, down 35.9% from the year before. It recorded a net loss of $3.9 million. The operating loss came to $1.9 million, an operating margin of -38494.6%. Diluted earnings per share were -$0.04. Over the twelve months ended Sep 30, 2025, revenue was $53,429 and net income was $4.1 million. Across the 5 fiscal years shown, revenue shrank from $59,568 in fiscal 2020 to $4,863 in fiscal 2024, about 46.5% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2025
Sep 30, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
FY 2015
Sep 30, 2015
Revenue
0
+1987.1%
0
-35.9%
0
-94.0%
0
+228.4%
0
-35.8%
0
—
—
—
—
—
Cost of revenue
0
-98.8%
0
-99.5%
0
-42.4%
0
+1423.3%
0
-81.1%
0
—
—
—
—
—
Gross profit
0
+130.3%
0
+102.4%
-0
+5.5%
-0
-1045.4%
0
+141.0%
-0
—
—
—
—
—
Selling, general and administrative
0
-67.5%
1
-49.3%
1
-18.7%
2
-30.8%
2
-42.1%
4
+78.0%
2
+29809.3%
0
-59.0%
0
-50.5%
0
+99.2%
0
Operating income
-1
+54.4%
-2
+10.0%
-2
+6.9%
-2
+30.8%
-3
+59.2%
-8
-36.0%
-6
-21486.3%
-0
+52.6%
-0
-55.2%
-0
-38.3%
-0
Pretax income
—
—
—
—
—
—
—
—
-0
—
—
Net income
4
+171.6%
-4
+0.5%
-4
-29.2%
-3
+19.2%
-4
+52.5%
-8
-28.3%
-6
-22920.3%
-0
+52.6%
-0
-159.9%
-0
+17.4%
-0
Net income to common
4
+168.7%
-4
-3.0%
-4
-27.1%
-3
+20.0%
-4
+59.6%
-10
—
—
—
—
—
Basic EPS
0.03
+157.6%
-0.04
+20.0%
-0.05
+0.0%
-0.05
—
—
—
—
—
—
—
Diluted EPS
0.03
+157.6%
-0.04
+20.0%
-0.05
—
—
—
—
—
—
—
—
Weighted average shares, basic
117
+19.3%
107
+45.9%
73
+10.8%
66
—
—
—
—
—
—
4
Weighted average shares, diluted
117
+19.3%
107
+45.9%
73
—
—
—
—
—
—
—
—
Other measures
Depreciation and amortization
—
0
-100.0%
0
-19.0%
0
+4.9%
0
+20.0%
0
+70.9%
0
—
—
—
—
EBITDA
—
-2
+8.5%
-2
+6.7%
-2
+31.2%
-3
+59.5%
-8
-35.9%
-6
—
—
—
—
Interest coverage
-1.36x
-1.71x
—
—
—
—
—
—
—
—
—
Margins
Gross margin
96.14%
80.51%
-2,181.22%
-139.34%
48.40%
-75.81%
—
—
—
—
—
Operating margin
-1,930.45%
-38,494.63%
-27,419.57%
-1,779.48%
-8,444.76%
-13,291.65%
—
—
—
—
—
Profit margin
7,692.13%
-80,917.38%
-52,092.78%
-2,434.69%
-9,890.66%
-13,371.54%
—
—
—
—
—
EBITDA margin
—
-38,494.63%
-26,968.05%
-1,745.83%
-8,339.38%
-13,235.22%
—
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OWPC (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Troy, MI
SEC filer status
, Emerging growth company
SEC CIK
1622244
Former names
One World Pharma, Inc. (until Nov 30, 2021); PUNTO GROUP, CORP. (until Jan 8, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.